Merck Net Income/Loss 2010-2025 | MRK

Merck net income/loss for the twelve months ending March 31, 2025 was $45.835B, a 1173.19% increase year-over-year.

  • Merck annual net income/loss for 2024 was $17.133B, a 4444.56% increase from 2023.
  • Merck annual net income/loss for 2023 was $0.377B, a 97.4% decline from 2022.
  • Merck annual net income/loss for 2022 was $14.526B, a 17.54% increase from 2021.

Merck Net Income/Loss 2010-2025 | MRK

  • Merck annual net income/loss for 2024 was $17.133B, a 4444.56% increase from 2023.
  • Merck annual net income/loss for 2023 was $0.377B, a 97.4% decline from 2022.
  • Merck annual net income/loss for 2022 was $14.526B, a 17.54% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B